Cart
sales@molnova.com
Aristololactam I
CAS No. 13395-02-3
Aristololactam I( —— )
Catalog No. M17961 CAS No. 13395-02-3
Aristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 176 | In Stock |
|
| 5MG | 136 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 370 | In Stock |
|
| 50MG | 533 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAristololactam I
-
NoteResearch use only, not for human use.
-
Brief DescriptionAristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.
-
DescriptionAristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway. The effects of Aristololactam I may be mediated by different mechanisms except TGF-beta1 pathway. 3. Aristololactam I may be one of toxic metabolites in Chinese herbs containing AA which participate in renal damage and fibrosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorCaspase-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13395-02-3
-
Formula Weight293.27
-
Molecular FormulaC17H11NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (42.62 mM)
-
SMILESCOC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC5=C3OCO5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ac-YVAD-CMK
Ac-YVAD-CMK (Ac-Tyr-Val-Ala-Asp-CMK) is a selective and irreversible inhibitor of Caspase-1 and inhibits pyroptosis, IL-1β and IL-18. Ac-YVAD-CMK shows neuroprotective and anti-inflammatory capacity.
-
Dupilumab
Dupilumab (REGN-668) is a fully human monoclonal antibody targeting the alpha subunit of the interleukin-4 receptor, thereby inhibiting IL-4 and IL-13 signaling.
-
SDZ 224-015
SDZ 224-015 is an orally active inhibitor of interleukin-1β (IL-1β) converting enzyme and caspase-1, exhibiting anti-COVID-19 and anti-inflammatory activity, and reducing carrageenan gum-induced paw edema in rats.
